What do systematic reviews say?

1400/250 ppm F (amine F/SnF2) toothpaste + mouthrinse, daily vs 1400/250 ppm F (NaF) toothpaste + mouthrinse, daily

The review found no eligible studies for this question.

• Fluorides for preventing early tooth decay (demineralised lesions) during fixed brace treatment 2019 · Cochrane All outcomes

  At debond (end of orthodontic treatment)
  Additional SoF Table 2. Adverse effects: none of the trials reported this outcome.
  0 studies
  No studies found

Patient-used 250 ppm F mouthrinse (100 ppm amine F/150 ppm NaF), daily vs 0 ppm F placebo mouthrinse, daily

The review found no eligible studies for this question.

• Fluorides for preventing early tooth decay (demineralised lesions) during fixed brace treatment 2019 · Cochrane All outcomes

  At debond (end of orthodontic treatment)
  SoF 4. Adverse effects: none of the trials reported this outcome.
  0 studies
  No studies found

Slow-release fluoride device (fluoride glass beads) vs Fluoride mouthrinse

• Fluorides for preventing early tooth decay (demineralised lesions) during fixed brace treatment 2019 · Cochrane All outcomes

  At debond; follow-up 19 months
  Additional SoF Table 3. Adverse effects: current design of the fluoride glass bead inadequate; high attrition partly due to bead breakages ('an improved method of attachment is needed'). 37 participants (1 RCT, Luther…
  1 study · 37 participants
  Very low

Resin-modified glass ionomer cement for bonding orthodontic brackets vs Composite resin for bonding brackets

• Fluorides for preventing early tooth decay (demineralised lesions) during fixed brace treatment 2019 · Cochrane All outcomes

  At debond; follow-up 17.6 months
  SoF 5. Adverse effects: no evidence that either intervention had adverse effects. 173 participants (1 RCT, Benson 2019); certainty LOW.
  1 study · 173 participants
  Low

Patient-used 5000 ppm F toothpaste, daily vs 1450 to 1500 ppm F toothpaste

The review found no eligible studies for this question.

• Fluorides for preventing early tooth decay (demineralised lesions) during fixed brace treatment 2019 · Cochrane All outcomes

  At debond (end of orthodontic treatment)
  SoF 3. Adverse effects: none of the trials reported this outcome.
  0 studies
  No studies found

12,500 ppm F (NaF/olaflur/dectaflur) amine fluoride gel vs Placebo gel

• Fluorides for preventing early tooth decay (demineralised lesions) during fixed brace treatment 2019 · Cochrane All outcomes

  At debond; mean follow-up 16.6 months
  Additional SoF Table 1. Adverse effects: with placebo gel 0.60%; with fluoride gel 0.00% (0 to 0); difference 0.60% fewer (0.60 fewer to 0.60 fewer); relative effect not estimable; 312 participants (1 RCT); certainty…
  1 study · 312 participants
  Very low

Professionally-applied 12,300 ppm F APF foam, every 2 months vs 0 ppm F placebo foam

The review found no eligible studies for this question.

• Fluorides for preventing early tooth decay (demineralised lesions) during fixed brace treatment 2019 · Cochrane All outcomes

  At debond (end of orthodontic treatment)
  SoF 2. Adverse effects: none of the trials reported this outcome.
  0 studies
  No studies found

Fluoride varnish vs Non-fluoride (placebo) varnish

• Fluorides for preventing early tooth decay (demineralised lesions) during fixed brace treatment 2019 · Cochrane All outcomes

  At debond; follow-up 1.7 years
  SoF 1. Adverse effects: no evidence that the intervention had adverse effects; only 1 participant with an adverse event and unclear if directly related to the intervention. 148 participants (1 RCT, Sonesson 2019);…
  1 study · 148 participants
  Low